このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Hikma Pharmaceuticals 将来の成長
Future 基準チェック /36
Hikma Pharmaceuticals利益と収益がそれぞれ年間16%と4%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に18.2% 14.8%なると予測されています。
主要情報
16.0%
収益成長率
14.8%
EPS成長率
| Pharmaceuticals 収益成長 | 14.2% |
| 収益成長率 | 4.0% |
| 将来の株主資本利益率 | 18.2% |
| アナリストカバレッジ | Good |
| 最終更新日 | 19 Jun 2024 |
今後の成長に関する最新情報
Recent updates
Is Hikma Pharmaceuticals PLC (LON:HIK) Trading At A 29% Discount?
Apr 24
Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Apr 02Hikma Pharmaceuticals PLC's (LON:HIK) Share Price Matching Investor Opinion
Feb 25Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Dec 27An Intrinsic Calculation For Hikma Pharmaceuticals PLC (LON:HIK) Suggests It's 43% Undervalued
Dec 12Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Sep 19Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Sep 01Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Jun 21Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 28% Above Its Share Price
Jun 02Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Mar 14Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Feb 21Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Sep 27Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 24These 4 Measures Indicate That Hikma Pharmaceuticals (LON:HIK) Is Using Debt Reasonably Well
Jun 06Here's Why Hikma Pharmaceuticals (LON:HIK) Can Manage Its Debt Responsibly
Feb 26Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 92% Above Its Share Price
Dec 01Is Hikma Pharmaceuticals (LON:HIK) Using Too Much Debt?
Nov 11Is There An Opportunity With Hikma Pharmaceuticals PLC's (LON:HIK) 32% Undervaluation?
Sep 02Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Aug 09Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 26% Below Their Intrinsic Value Estimate
May 21Hikma Pharmaceuticals (LON:HIK) Seems To Use Debt Quite Sensibly
May 03It's Unlikely That Hikma Pharmaceuticals PLC's (LON:HIK) CEO Will See A Huge Pay Rise This Year
Apr 16How Does Hikma Pharmaceuticals PLC (LON:HIK) Stand Up To These Simple Dividend Safety Checks?
Apr 13Hikma Pharmaceuticals PLC (LON:HIK) Looks Interesting, And It's About To Pay A Dividend
Mar 14Hikma Pharmaceuticals PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 28I Ran A Stock Scan For Earnings Growth And Hikma Pharmaceuticals (LON:HIK) Passed With Ease
Feb 22Is There An Opportunity With Hikma Pharmaceuticals PLC's (LON:HIK) 23% Undervaluation?
Feb 03業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | 3,251 | 477 | 449 | 703 | 8 |
| 12/31/2025 | 3,087 | 451 | 505 | 745 | 10 |
| 12/31/2024 | 2,988 | 414 | 413 | 643 | 10 |
| 12/31/2023 | 2,875 | 190 | 404 | 608 | N/A |
| 9/30/2023 | 2,803 | 168 | 389 | 596 | N/A |
| 6/30/2023 | 2,731 | 146 | 373 | 583 | N/A |
| 3/31/2023 | 2,624 | 167 | 344 | 557 | N/A |
| 12/31/2022 | 2,517 | 188 | 314 | 530 | N/A |
| 9/30/2022 | 2,534 | 267 | 325 | 557 | N/A |
| 6/30/2022 | 2,550 | 346 | 335 | 583 | N/A |
| 3/31/2022 | 2,552 | 384 | 372 | 611 | N/A |
| 12/31/2021 | 2,553 | 421 | 409 | 638 | N/A |
| 9/30/2021 | 2,489 | 444 | 294 | 517 | N/A |
| 6/30/2021 | 2,425 | 467 | 179 | 396 | N/A |
| 3/31/2021 | 2,383 | 449 | 210 | 430 | N/A |
| 12/31/2020 | 2,341 | 431 | 240 | 464 | N/A |
| 9/30/2020 | 2,317 | 472 | 306 | 521 | N/A |
| 6/30/2020 | 2,292 | 513 | 372 | 577 | N/A |
| 3/31/2020 | 2,250 | 500 | 329 | 525 | N/A |
| 12/31/2019 | 2,207 | 486 | 286 | 472 | N/A |
| 9/30/2019 | 2,173 | 424 | 283 | 452 | N/A |
| 6/30/2019 | 2,138 | 361 | 279 | 432 | N/A |
| 3/31/2019 | 2,104 | 322 | 285 | 431 | N/A |
| 12/31/2018 | 2,070 | 282 | 291 | 430 | N/A |
| 9/30/2018 | 2,045 | -262 | 275 | 417 | N/A |
| 6/30/2018 | 2,020 | -806 | 259 | 403 | N/A |
| 3/31/2018 | 1,978 | -824 | 276 | 423 | N/A |
| 12/31/2017 | 1,936 | -843 | 292 | 443 | N/A |
| 9/30/2017 | 1,950 | -338 | N/A | 431 | N/A |
| 6/30/2017 | 1,963 | 166 | N/A | 419 | N/A |
| 3/31/2017 | 1,957 | 161 | N/A | 356 | N/A |
| 12/31/2016 | 1,950 | 155 | N/A | 293 | N/A |
| 9/30/2016 | 1,782 | 166 | N/A | 317 | N/A |
| 6/30/2016 | 1,613 | 176 | N/A | 340 | N/A |
| 3/31/2016 | 1,527 | 214 | N/A | 353 | N/A |
| 12/31/2015 | 1,440 | 252 | N/A | 366 | N/A |
| 9/30/2015 | 1,450 | 248 | N/A | 358 | N/A |
| 6/30/2015 | 1,460 | 243 | N/A | 350 | N/A |
| 3/31/2015 | 1,475 | 261 | N/A | 388 | N/A |
| 12/31/2014 | 1,489 | 278 | N/A | 425 | N/A |
| 9/30/2014 | 1,477 | 293 | N/A | 413 | N/A |
| 6/30/2014 | 1,465 | 308 | N/A | 401 | N/A |
| 3/31/2014 | 1,415 | 260 | N/A | 369 | N/A |
| 12/31/2013 | 1,365 | 212 | N/A | 337 | N/A |
| 9/30/2013 | 1,290 | 172 | N/A | 305 | N/A |
| 6/30/2013 | 1,215 | 133 | N/A | 273 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: HIKの予測収益成長率 (年間16% ) は 貯蓄率 ( 1.8% ) を上回っています。
収益対市場: HIKの収益 ( 16% ) はUK市場 ( 13.1% ) よりも速いペースで成長すると予測されています。
高成長収益: HIKの収益は増加すると予測されていますが、大幅には増加しません。
収益対市場: HIKの収益 ( 4% ) UK市場 ( 3.6% ) よりも速いペースで成長すると予測されています。
高い収益成長: HIKの収益 ( 4% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: HIKの 自己資本利益率 は、3年後には低くなると予測されています ( 18.2 %)。